Keyphrases
Pathogenic Pathways
100%
Diabetes
100%
Diabetic Keratopathy
100%
Fenofibrate
80%
Diabetic
60%
Corneal Model
40%
Nerve Fiber Degeneration
40%
Transgenic Mice
40%
Cornea
40%
Non-diabetic
40%
Diabetic Rats
40%
Mitochondrial Function
40%
Corneal Nerves
40%
Subbasal Nerve Fibers
20%
Fenofibric Acid
20%
Corneal Defects
20%
Corneal Ulcer
20%
3D Humans
20%
Donor Cornea
20%
Longitudinal Clinical Study
20%
Eye Drops
20%
Novel Therapies
20%
Therapeutic Effect
20%
Novel Therapeutic Targets
20%
Overexpressing
20%
Oxidative Inflammation
20%
Vision Loss
20%
Seahorse Analysis
20%
Oxidative Stress
20%
Therapeutic Efficacy
20%
Neurotrophic Factors
20%
Knock-in Mouse Model
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Retina
20%
Overexpression
20%
Age-matched
20%
Active Metabolite
20%
Attenuation
20%
Pathogenic Mechanism
20%
Peroxisome Proliferator-activated Receptor
20%
Diabetic Retinopathy
20%
Diabetic Mice
20%
Topical Application
20%
Human Cornea
20%
Corneal Nerve Fibers
20%
Nerve Degeneration
20%
Corneal Nerve Density
20%
Diabetes Complications
20%
Effective Compounds
20%
Type 1 Diabetes Mellitus (T1DM)
20%
Human Donor
20%
Corneal Tissue
20%
3D in Vitro Models
20%
Corneal Sensitivity
20%
Neuroprotective Effect
20%
Pathological Role
20%
WT Mice
20%
Neuroprotective
20%
Medicine and Dentistry
Peroxisome Proliferator Activated Receptor
100%
Bullous Keratopathy
100%
Diabetes Mellitus
31%
Diabetes
22%
Fenofibrate
18%
Corneal Nerve
18%
Transgenic Mouse
9%
In Vitro
9%
Downregulation
9%
Nerve Fiber Degeneration
9%
Neuroprotective Agent
9%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Keratopathy
100%
Diabetes Mellitus
31%
Fenofibrate
18%
Transgenic Mouse
9%
Nerve Fiber Degeneration
9%
Neuroprotective Agent
9%